These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 8831747)
21. [Subsegmental transcatheter hepatic arterial embolization under balloon occlusion of the corresponding hepatic vein with SMANCS]. Shibata H; Sogabe M; Tsutsui A; Yokoi T; Morimoto M; Fukuda T; Hayashi S; Muguruma N; Ohkita Y; Okahisa T; Okamura S; Ito S Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():133-40. PubMed ID: 9512701 [TBL] [Abstract][Full Text] [Related]
22. [Our initial experience with SMANCS in TAE for liver cancer]. Fujita M; Inoue E; Kuroda C; Kasugai H; Sasaki Y; Nakano H; Imaoka S Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():105-8. PubMed ID: 9512697 [TBL] [Abstract][Full Text] [Related]
23. [Transcatheter arterial embolization with SMANCS and epiADM for hepatocellular carcinoma]. Ihaya T; Ametani M; Matsusue E Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():109-15. PubMed ID: 9512698 [TBL] [Abstract][Full Text] [Related]
24. [Comparative studies on the antitumor activities and side effects of segmental SMANCS/Lip-TAE with segmental SMANCS/Lip-TAI for hepatocellular carcinoma]. Matoba M; Okimura T; Yamamoto I Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():73-9. PubMed ID: 9512692 [TBL] [Abstract][Full Text] [Related]
25. [Good response in case of hepatocellular carcinoma; a case report of interdisciplinary local therapy]. Niinobu T; Shibata T; Shibata N; Takada T; Kitada M; Tsukahara Y; Hata S; Ikeda K; Hayashida H; Ogawa M; Hayashi N; Akazawa K; Takami M Gan To Kagaku Ryoho; 1998 Jul; 25(9):1379-81. PubMed ID: 9703833 [TBL] [Abstract][Full Text] [Related]
26. [Clinical experience of treatment of liver metastasis of renal cell carcinoma treated with SMANCS/Lipiodol therapy]. Umeda S; Ito K; Takahashi E; Kimura F; Sumitomo M; Kaji T; Hayakawa M; Asano T Hinyokika Kiyo; 2010 Oct; 56(10):543-9. PubMed ID: 21063157 [TBL] [Abstract][Full Text] [Related]
27. [Styrene maleic acid neocarzinostatin-transcatheter embolization for hepatocellular carcinoma--third report]. Hasegawa I; Hirashima N Gan To Kagaku Ryoho; 2002 Feb; 29(2):253-9. PubMed ID: 11865632 [TBL] [Abstract][Full Text] [Related]
28. [SMANCS/TAE for hepatocellular carcinoma: comparison with SMANCS/TAI]. Shimizu T; Endou H Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():80-3. PubMed ID: 9512693 [TBL] [Abstract][Full Text] [Related]
29. [Treatment of hepatocellular carcinoma by segmental SMANCS Lipiodol-TAE]. Hayashi T; Uchida H; Matsuo N; Sakaguchi H; Anai H; Tanaka T; Yamamoto T; Ooue S; Yoshioka T; Makutani S; Oishi H Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():116-24. PubMed ID: 9512699 [TBL] [Abstract][Full Text] [Related]
30. [Outcome of TAE for hepatocellular carcinoma: comparative study of SMANCS-TAE and non-SMANCS/LpTAE]. Itsubo M; Koike K; Toda G Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():84-9. PubMed ID: 9512694 [TBL] [Abstract][Full Text] [Related]
31. [Effect of arterial administration of a high molecular weight anti-tumor agent styrene maleic acid neocarzinostatin for multiple small liver cancer]. Ikeda K; Saitoh S; Kumada H Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():19-23. PubMed ID: 9512682 [TBL] [Abstract][Full Text] [Related]
32. [Advantages and disadvantages of SMANCS-Lipiodol intrahepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma]. Suzuki M; Fukuhara K; Unno M; Endoh K; Takeuchi H; Kodama H; Oikawa M; Matsuno S Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():39-45. PubMed ID: 9512686 [TBL] [Abstract][Full Text] [Related]
33. [Arterial administration of oily anticancer agents dissolved in lipiodol fluid in recurrence of hepatoma after hepatic resection and in metastatic liver cancer]. Ohtsuka N; Konno T Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1351-8. PubMed ID: 2837992 [TBL] [Abstract][Full Text] [Related]
34. [A case of recurrent multiple HCC after surgical resection showing regression by two TAEs using 5-FU and zinostatin stimalamer]. Takiya S; Sawada T; Takahashi K; Tagaya T; Fukuzawa Y; Kato K; Murata K; Ikeda H Gan To Kagaku Ryoho; 1996 Aug; 23(9):1205-8. PubMed ID: 8751812 [TBL] [Abstract][Full Text] [Related]
35. [Combination of transcatheter arterial infusion of SMANCS and embolization on hepatocellular carcinoma]. Hirashima N; Kumada K; Sakakibara K; Hirai T; Nemoto S; Matsuura H; Itazu I; Nojiri O; Kano H Gan To Kagaku Ryoho; 1995 Sep; 22(10):1411-5. PubMed ID: 7668880 [No Abstract] [Full Text] [Related]
36. [Pathologic study of hepatocellular carcinoma treated by TAI and TAE with SMANCS]. Takayasu K; Iwata R; Furukawa T; Nakanishi Y; Sakamoto M Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():70-2. PubMed ID: 9512691 [No Abstract] [Full Text] [Related]
37. [Results of SMANCS/Lipiodol injection therapy for multiple intrahepatic recurrence of hepatocellular carcinoma]. Nakaba H; Hashimoto T; Sunada S; Akamatsu D; Ito A; Teramoto S; Ohara S; Katayama S Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():46-50. PubMed ID: 9512687 [TBL] [Abstract][Full Text] [Related]
38. [Targeting chemotherapy of hepatocellular carcinoma by arterial administration of anticancer agents dissolved in lipiodol]. Konno T Gan To Kagaku Ryoho; 1987 Feb; 14(2):373-80. PubMed ID: 3028275 [TBL] [Abstract][Full Text] [Related]
39. How can we avert hepatic vascular complications in SMANCS therapy for hepatocellular carcinoma? Okada S J Gastroenterol; 2000; 35(5):407-9. PubMed ID: 10832680 [No Abstract] [Full Text] [Related]
40. Total necrosis of hepatocellular carcinoma with a combination therapy of arterial infusion of chemotherapeutic lipiodol and transcatheter arterial embolization: report of 14 cases. Kenji J; Hyodo I; Tanimizu M; Tanada M; Nishikawa Y; Hosokawa Y; Mandai K; Moriwaki S Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-71-S6-80. PubMed ID: 9151920 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]